Federal Register / Vol. 65, No. 199 / Friday, October 13, 2000 / Notices 60977

manufacturer of this basic class of

controlled substance may file written

comments on or objections to the

application described above and may, at

the same time, file a written request for

a hearing on such application in

accordance with 21 CFR 1301.43 in

such form as prescribed by 21 CFR

1316.47.

Any such comments, objections or

requests for a hearing may be addressed,

in quintuplicate, to the Deputy Assistant

Administrator, Office of Diversion

Control, Drug Enforcement

Administration, United States

Department of Justice, Washington, DC

20537, Attention: DEA Federal Register

representative (CCR), and must be filed

no later than November 13, 2000.

This procedure is to be conducted

simultaneously with and independent

of the procedures described in 21 CFR

1301.34(b), (c), (d), (e), and (f). As noted

in a previous notice at 40 FR 43745–46

(September 23, 1975), all applicants for

registration to import a basic class of

any controlled substance in Schedule I

or II are and will continue to be required

to demonstrate to the Deputy Assistant

Administrator, Office of Diversion

Control, Drug Enforcement

Administration that the requirements

for such registration pursuant to 21

U.S.C. 958(a), 21 U.S.C. 823(a), and 21

CFR 1301.34(a), (b), (c), (d), (e), and (f)

are satisfied.

Dated: September 26, 2000.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–26372 Filed 10–12–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated May 19, 2000, and

published in the Federal Register on

May 30, 2000, (65 FR 34498), Chemic

Laboratories, Inc., 480 Neponset Street,

Building 7C, Canton, Massachusetts

02021, made application to the Drug

Enforcement Administration (DEA) to

be registered as a bulk manufacturer of

cocaine (9041), a basic class of

controlled substance listed in Schedule

II.

The firm plans to bulk manufacture

small quantities of cocaine derivative

for a customer.

DEA has considered the factors in

Title 21, United States Code, Section

823(a) and determined that the

registration of Chemic Laboratories, Inc.

to manufacture is consistent with the

public interest at this time. DEA has

investigated Chemic Laboratories, Inc.

to ensure that the company’s

registration is consistent with the public

interest. These investigations have

included inspection and testing of the

company’s physical security systems,

verification of the company’s

compliance with state and local laws,

and a review of the company’s

background and history. Therefore,

pursuant to 21 U.S.C. 823 and 28 CFR

0.100 and 0.104, the Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic class of controlled substance

listed above is granted.

Dated: August 18, 2000.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–26366 Filed 10–12–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importer of Controlled Substances;

Notice of Registration

By Notice dated July 11, 2000, and

published in the Federal Register on

August 1, 2000, (65 FR 46951),

Chiragene, Inc., 7 Powder Horn Drive,

Warren, New Jersey 07059, made

application by renewal to the Drug

Enforcement Administration (DEA) to

be registered as an importer of

phenylacetone (8501), a basic class of

controlled substance listed in Schedule

II.

The firm plans to import the

phenylacetone to manufacture

amphetamine.

No comments or objections have been

received. DEA has considered the

factors in Title 21, United States Code,

Section 823(a) and determined that the

registration of Chiragene, Inc. to import

phenylacetone is consistent with the

public interest and with United States

obligations under international treaties,

conventions, or protocols in effect on

May 1, 1971, at this time. DEA has

investigated Chiragene, Inc. on a regular

basis to ensure that the company’s

continued registration is consistent with

the public interest. These investigations

have included inspection and testing of

the company’s physical security

systems, audits of the company’s

records, verification of the company’s

compliance with state and local laws,

and a review of the company’s

background and history. Therefore,

pursuant to Section 1008(a) of the

Controlled Substances Import and

Export Act and in accordance with Title

21, Code of Federal Regulations, Section

1301.34, the above firm is granted

registration as an importer of the basic

class of controlled substance listed

above.

Dated: October 4, 2000.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–26368 Filed 10–12–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importation of Controlled Substances;

Notice of Withdrawal

As set forth in the Federal Register

(FR Doc. 00–7870) Vol. 65, No. 62 at

page 16963, dated March 30, 2000,

Chirex Technology Center, Inc., DBA

Chirex Cauldron, 383 Phoenixville Pike,

Malvern, Pennsylvania 19355, made

application to the Drug Enforcement

Administration to be registered as an

importer of amphetamine (1100).

Two registered bulk manufacturers of

amphetamine requested a hearing to

deny the proposed registration of Chirex

Technology Center, Inc. Chirex

Technology Center, Inc. requested by

letter that its application be withdrawn.

Therefore, Chirex Technology Center,

Inc,’s application to import

amphetamine is hereby with drawn.

Dated: September 26, 2000.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 00–26374 Filed 10–12–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated May 1, 2000, and

published in the Federal Register on

May 12, 2000, (65 FR 30614), Dupont

Pharmaceuticals, 1000 Stewart Avenue,

Garden City, New York 11530, made

application by renewal to the Drug

Enforcement Administration (DEA) to

be registered as a bulk manufacturer of